vs
STANDARD BIOTOOLS INC.(LAB)与LiveOne, Inc.(LVO)财务数据对比。点击上方公司名可切换其他公司
LiveOne, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.0倍($20.3M vs $19.6M),LiveOne, Inc.净利率更高(-20.1% vs -177.4%,领先157.3%),STANDARD BIOTOOLS INC.同比增速更快(-11.5% vs -31.2%),LiveOne, Inc.自由现金流更多($-2.9M vs $-23.1M),过去两年STANDARD BIOTOOLS INC.的营收复合增速更高(-12.2% vs -19.0%)
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
Live Nation Entertainment是一家美国跨国娱乐企业,2010年由原Live Nation与Ticketmaster合并成立。目前两大品牌仍作为子品牌独立运营,业务覆盖全球现场娱乐演出推广与票务销售,同时自营多座娱乐场馆,也提供艺人经纪管理服务。
LAB vs LVO — 直观对比
营收规模更大
LVO
是对方的1.0倍
$19.6M
营收增速更快
LAB
高出19.7%
-31.2%
净利率更高
LVO
高出157.3%
-177.4%
自由现金流更多
LVO
多$20.2M
$-23.1M
两年增速更快
LAB
近两年复合增速
-19.0%
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $19.6M | $20.3M |
| 净利润 | $-34.7M | $-4.1M |
| 毛利率 | 48.5% | 18.8% |
| 营业利润率 | -168.5% | -9.6% |
| 净利率 | -177.4% | -20.1% |
| 营收同比 | -11.5% | -31.2% |
| 净利润同比 | -28.8% | 22.3% |
| 每股收益(稀释后) | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LAB
LVO
| Q4 25 | — | $20.3M | ||
| Q3 25 | $19.6M | $18.8M | ||
| Q2 25 | $21.8M | $19.2M | ||
| Q1 25 | $40.8M | $19.3M | ||
| Q4 24 | — | $29.4M | ||
| Q3 24 | $22.1M | $32.6M | ||
| Q2 24 | $22.5M | $33.1M | ||
| Q1 24 | $45.5M | $30.9M |
净利润
LAB
LVO
| Q4 25 | — | $-4.1M | ||
| Q3 25 | $-34.7M | $-5.5M | ||
| Q2 25 | $-33.5M | $-3.6M | ||
| Q1 25 | $-26.0M | $-10.4M | ||
| Q4 24 | — | $-5.2M | ||
| Q3 24 | $-26.9M | $-1.9M | ||
| Q2 24 | $-45.7M | $-1.2M | ||
| Q1 24 | $-32.2M | $-2.3M |
毛利率
LAB
LVO
| Q4 25 | — | 18.8% | ||
| Q3 25 | 48.5% | 13.8% | ||
| Q2 25 | 48.8% | 12.4% | ||
| Q1 25 | 48.4% | 30.8% | ||
| Q4 24 | — | 24.3% | ||
| Q3 24 | 54.9% | 24.8% | ||
| Q2 24 | 46.1% | 24.2% | ||
| Q1 24 | 53.1% | 25.5% |
营业利润率
LAB
LVO
| Q4 25 | — | -9.6% | ||
| Q3 25 | -168.5% | -24.4% | ||
| Q2 25 | -118.1% | -21.0% | ||
| Q1 25 | -80.8% | -55.8% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | -120.9% | -4.3% | ||
| Q2 24 | -134.5% | -2.4% | ||
| Q1 24 | -132.2% | -3.7% |
净利率
LAB
LVO
| Q4 25 | — | -20.1% | ||
| Q3 25 | -177.4% | -29.5% | ||
| Q2 25 | -153.7% | -18.7% | ||
| Q1 25 | -63.8% | -54.2% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | -122.0% | -5.7% | ||
| Q2 24 | -203.3% | -3.5% | ||
| Q1 24 | -70.6% | -7.4% |
每股收益(稀释后)
LAB
LVO
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.07 | — | ||
| Q2 24 | $-0.12 | — | ||
| Q1 24 | $-0.27 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $8.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $-19.0M |
| 总资产 | $539.6M | $52.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
LAB
LVO
| Q4 25 | — | $8.6M | ||
| Q3 25 | $129.4M | $11.7M | ||
| Q2 25 | $158.6M | $11.9M | ||
| Q1 25 | $150.9M | $4.1M | ||
| Q4 24 | — | $10.9M | ||
| Q3 24 | $210.6M | $11.1M | ||
| Q2 24 | $269.8M | $6.2M | ||
| Q1 24 | $287.1M | $7.0M |
总债务
LAB
LVO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益
LAB
LVO
| Q4 25 | — | $-19.0M | ||
| Q3 25 | $399.7M | $-16.2M | ||
| Q2 25 | $424.5M | $-20.8M | ||
| Q1 25 | $454.6M | $-17.8M | ||
| Q4 24 | — | $-8.4M | ||
| Q3 24 | $489.3M | $-4.7M | ||
| Q2 24 | $510.3M | $-3.8M | ||
| Q1 24 | $577.3M | $-8.7M |
总资产
LAB
LVO
| Q4 25 | — | $52.3M | ||
| Q3 25 | $539.6M | $53.8M | ||
| Q2 25 | $557.0M | $48.9M | ||
| Q1 25 | $579.6M | $40.5M | ||
| Q4 24 | — | $56.2M | ||
| Q3 24 | $681.5M | $67.2M | ||
| Q2 24 | $708.7M | $64.6M | ||
| Q1 24 | $777.7M | $63.9M |
负债/权益比
LAB
LVO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-2.3M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-2.9M |
| 自由现金流率自由现金流/营收 | -118.1% | -14.4% |
| 资本支出强度资本支出/营收 | 4.5% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-16.2M |
8季度趋势,按日历期对齐
经营现金流
LAB
LVO
| Q4 25 | — | $-2.3M | ||
| Q3 25 | $-22.2M | $-3.2M | ||
| Q2 25 | $-20.7M | $-3.0M | ||
| Q1 25 | $-30.3M | $-4.3M | ||
| Q4 24 | — | $3.5M | ||
| Q3 24 | $-27.9M | $5.8M | ||
| Q2 24 | $-39.0M | $1.3M | ||
| Q1 24 | $-62.5M | $3.0M |
自由现金流
LAB
LVO
| Q4 25 | — | $-2.9M | ||
| Q3 25 | $-23.1M | $-4.0M | ||
| Q2 25 | $-22.6M | $-4.1M | ||
| Q1 25 | $-35.3M | $-5.2M | ||
| Q4 24 | — | $2.7M | ||
| Q3 24 | $-30.1M | $5.2M | ||
| Q2 24 | $-41.0M | $606.0K | ||
| Q1 24 | $-63.3M | $2.1M |
自由现金流率
LAB
LVO
| Q4 25 | — | -14.4% | ||
| Q3 25 | -118.1% | -21.5% | ||
| Q2 25 | -103.6% | -21.2% | ||
| Q1 25 | -86.6% | -26.9% | ||
| Q4 24 | — | 9.2% | ||
| Q3 24 | -136.4% | 15.9% | ||
| Q2 24 | -182.2% | 1.8% | ||
| Q1 24 | -138.9% | 6.8% |
资本支出强度
LAB
LVO
| Q4 25 | — | 3.2% | ||
| Q3 25 | 4.5% | 4.4% | ||
| Q2 25 | 8.7% | 5.3% | ||
| Q1 25 | 12.4% | 4.8% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | 10.2% | 1.8% | ||
| Q2 24 | 8.6% | 2.2% | ||
| Q1 24 | 1.7% | 3.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
LVO
| Advertising | $15.8M | 78% |
| Membership Services | $2.9M | 14% |
| Merchandising Revenue | $1.6M | 8% |